PROTAGONIST THERAPEUTICS INC's ticker is and the CUSIP is 38141G107. A total of 1 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,052,325 | -39.6% | 63,089 | -0.1% | 0.78% | -37.3% |
Q2 2023 | $1,743,402 | +20.1% | 63,121 | 0.0% | 1.24% | +14.2% |
Q1 2023 | $1,451,783 | +110.8% | 63,121 | 0.0% | 1.08% | +104.0% |
Q4 2022 | $688,650 | -37.6% | 63,121 | -51.8% | 0.53% | -40.3% |
Q3 2022 | $1,103,000 | -16.7% | 130,881 | -18.0% | 0.89% | -7.3% |
Q2 2022 | $1,324,000 | – | 159,592 | – | 0.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Twin Lakes Capital Management, LLC | 63,089 | $1,052,325 | 0.78% |